Amanote Research
Register
Sign In
Pmu37 - Introduction Rate of New Hemato-Oncology Drugs in Catalonia
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.1873
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
M Roig
L Guarga
M Pastor
C Zara
C Pontes
J Delgadillo
Publisher
Elsevier BV
Related search
Evaluation of Conflict of Interest in Economic Analyses of New Drugs Used in Oncology
JAMA - Journal of the American Medical Association
Medicine
ReDO_DB: The Repurposing Drugs in Oncology Database
ecancermedicalscience
Cancer Research
Oncology
Time to Reimbursement for Oncology Drugs in EU5
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn320 - Recommendations of Spanish Therapeutic Positioning Reports for New Oncology Drugs Since Year 2013
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn292 - Cancer Drugs in Germany: Hta Decisions of New and Innovative Oncology Drugs in Germany – An Analysis Using the Prismaccess® Database
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Drugs Symposium: Introduction
Journal of Medical Ethics
Arts
Humanities
Legal Aspects
Health Policy
Health
Ethics
Issues
Reimbursement Decisions in Oncology Drugs: An International Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Predicting Post-Amnog Rebate Outcomes for Oncology Drugs
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Perspectives in Oncology: A New Article Type for Medical Oncology
Medical Oncology
Medicine
Cancer Research
Oncology
Hematology